Form 8-K - Current report:
SEC Accession No. 0002036042-25-000018
Filing Date
2025-06-13
Accepted
2025-06-13 16:09:06
Documents
12
Period of Report
2025-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K sion-20250612.htm   iXBRL 8-K 30929
  Complete submission text file 0002036042-25-000018.txt   150472

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sion-20250612.xsd EX-101.SCH 1822
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sion-20250612_lab.xml EX-101.LAB 22777
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sion-20250612_pre.xml EX-101.PRE 13073
14 EXTRACTED XBRL INSTANCE DOCUMENT sion-20250612_htm.xml XML 2933
Mailing Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451
Business Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451 617-819-2020
Sionna Therapeutics, Inc. (Filer) CIK: 0002036042 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42504 | Film No.: 251046594
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)